Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
(Un)conventional combinations: At the origins of breakthrough inventions |
0 |
0 |
1 |
11 |
0 |
0 |
3 |
43 |
A Comparison of U.S. And European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
393 |
A Comparison of U.S. and European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
65 |
0 |
0 |
1 |
340 |
A Few Special Cases: Scientific Creativity and Network Dynamics in the Field of Rare Diseases |
0 |
0 |
0 |
24 |
0 |
1 |
2 |
160 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
80 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
40 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
5 |
1 |
1 |
2 |
84 |
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
65 |
A Trick of the (Pareto) Tail |
0 |
0 |
0 |
54 |
0 |
0 |
1 |
189 |
An extreme value analysis of the last century crises across industries in the U.S. economy |
0 |
0 |
0 |
13 |
0 |
1 |
2 |
59 |
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks |
0 |
0 |
1 |
24 |
0 |
0 |
2 |
145 |
Biomedical Innovation Clusters |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
31 |
Brain-Circulation Network: The Global Mobility of the Life Scientists |
0 |
0 |
12 |
97 |
2 |
4 |
27 |
250 |
Cluster analysis of weighted bipartite networks: a new copula-based approach |
0 |
0 |
0 |
53 |
0 |
0 |
0 |
52 |
Co-evolution of Organizational Forms and Technology |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
248 |
Co-experience Network Dynamics: Lessons from the Dance Floor |
0 |
0 |
0 |
25 |
0 |
0 |
0 |
73 |
Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry |
0 |
0 |
0 |
234 |
0 |
0 |
0 |
457 |
Crescita proporzionale e politiche pubbliche: proposte per una sintesi evolutiva |
0 |
0 |
0 |
19 |
0 |
0 |
1 |
115 |
Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali |
0 |
0 |
0 |
13 |
0 |
0 |
0 |
85 |
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure |
1 |
1 |
2 |
150 |
2 |
2 |
5 |
513 |
From La Bohème to La Wally: How Organizational Status Affects the (Un)conventionality of Opera Repertoires |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
51 |
Global Networks of Trade and Bits |
0 |
0 |
0 |
55 |
0 |
0 |
0 |
134 |
Global Value Trees |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
28 |
Global Virtual Water Trade: Integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
0 |
48 |
0 |
0 |
5 |
74 |
Global Virtual Water Trade: integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
1 |
37 |
0 |
0 |
2 |
72 |
Global value trees |
0 |
0 |
0 |
65 |
0 |
0 |
0 |
49 |
Homophily and Triadic Closure in Evolving Social Networks |
0 |
0 |
1 |
60 |
1 |
1 |
3 |
97 |
I Farmaci Oncologici in Italia: innovazione e sostenibilità economica |
1 |
1 |
1 |
54 |
1 |
3 |
9 |
236 |
Identifying Geographic Clusters: A Network Analytic Approach |
0 |
0 |
0 |
56 |
0 |
0 |
1 |
62 |
Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato |
0 |
0 |
0 |
14 |
0 |
0 |
2 |
113 |
Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico |
0 |
0 |
0 |
23 |
0 |
0 |
5 |
141 |
Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
0 |
67 |
0 |
0 |
0 |
127 |
Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
0 |
151 |
0 |
0 |
0 |
259 |
Innovation and Corporate Growth in the Evolution of the Drug Industry |
0 |
0 |
1 |
431 |
0 |
1 |
11 |
981 |
Innovation, trade and the size of exporting firms |
0 |
0 |
0 |
42 |
0 |
0 |
2 |
71 |
Is There a Productivity Crisis in Pharmaceutical R&D? |
0 |
0 |
0 |
11 |
0 |
2 |
2 |
59 |
La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale |
0 |
0 |
1 |
16 |
0 |
0 |
2 |
119 |
Market Structure and Drug Innovation |
0 |
0 |
0 |
30 |
0 |
1 |
3 |
141 |
Medical Devices Competitiveness and Impact on Public Health Expenditure |
1 |
1 |
2 |
190 |
4 |
4 |
7 |
774 |
Medical Devices: Competitiveness and Impact on Public Health Expenditure |
0 |
0 |
2 |
33 |
0 |
1 |
5 |
178 |
Missing Links in Multiple Trade Networks |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
56 |
Monthly Report No. 03/2020 |
0 |
0 |
0 |
4 |
0 |
0 |
7 |
35 |
Networks Dynamics in the Pharmaceutical Industry |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
254 |
Networks of innovators within and across borders. Evidence from patent data |
0 |
0 |
1 |
114 |
1 |
1 |
3 |
244 |
Nuove politiche per l'innovazione nel settore delle scienze della vita |
0 |
0 |
1 |
7 |
0 |
0 |
1 |
97 |
On Firm Growth in Networks |
0 |
0 |
1 |
20 |
0 |
0 |
1 |
112 |
On Size and Growth of Business Firms |
0 |
0 |
0 |
35 |
1 |
1 |
3 |
339 |
Pareto versus lognormal: a maximum entropy test |
1 |
1 |
3 |
98 |
2 |
2 |
5 |
204 |
Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
1 |
110 |
0 |
1 |
2 |
194 |
Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
0 |
117 |
1 |
3 |
6 |
321 |
Patent Value and R&D Competition |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
106 |
Preferential attachment and growth dynamics in complex systems |
0 |
0 |
0 |
19 |
0 |
1 |
1 |
114 |
Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals |
0 |
0 |
0 |
251 |
0 |
0 |
1 |
524 |
Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte |
0 |
0 |
2 |
11 |
0 |
0 |
3 |
56 |
Radical Innovation and Network Evolution |
0 |
0 |
1 |
142 |
0 |
0 |
1 |
345 |
Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica |
0 |
0 |
1 |
16 |
0 |
0 |
4 |
114 |
Statistical Properties of Business Firms Structure and Growth |
0 |
0 |
0 |
18 |
0 |
0 |
1 |
84 |
Stochastic Trade Networks |
0 |
0 |
0 |
30 |
0 |
0 |
1 |
96 |
Stochastic Trade Networks |
0 |
0 |
0 |
91 |
0 |
2 |
3 |
203 |
Structure of Business Firm Networks and Scale-Free Models |
0 |
0 |
0 |
53 |
0 |
1 |
1 |
238 |
Structure of Business Firm Networks and Scale-Free Models |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
95 |
Systemic importance of financial institutions: from a global to a local perspective? A network theory approach |
0 |
0 |
0 |
93 |
0 |
0 |
1 |
133 |
Systemic importance of financial institutions: regulations, research, open issues, proposals |
0 |
0 |
0 |
50 |
0 |
0 |
1 |
204 |
Systemic risk and banking regulation: some facts on the new regulatory framework |
0 |
0 |
0 |
137 |
0 |
0 |
0 |
223 |
Talents from Abroad. Foreign Managers and Productivity in the United Kingdom |
0 |
0 |
0 |
54 |
1 |
2 |
2 |
64 |
Technological Regimes and the Growth of Networks An Empirical Analysis |
0 |
0 |
0 |
129 |
0 |
0 |
1 |
356 |
The Global Health Networks: A Comparative Analysis of Tuberculosis, Malaria and Pneumonia Using Social Media Data |
0 |
0 |
1 |
76 |
1 |
3 |
9 |
108 |
The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
0 |
0 |
0 |
21 |
0 |
0 |
0 |
121 |
The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
1 |
1 |
1 |
169 |
1 |
1 |
4 |
1,658 |
The Indirect Effects of FDI on Trade: A Network Perspective |
0 |
0 |
1 |
47 |
0 |
0 |
5 |
104 |
The Indirect Effects of FDI on Trade: A Network Perspective |
0 |
0 |
0 |
38 |
0 |
0 |
0 |
39 |
The Nature and the Extent of the Market for Technology in Biopharmaceuticals |
0 |
0 |
3 |
47 |
0 |
0 |
3 |
186 |
The Network of U.S. Mutual Fund Investments: Diversification, Similarity and Fragility throughout the Global Financial Crisis |
0 |
0 |
2 |
23 |
1 |
1 |
4 |
41 |
The Relation Between Global Migration and Trade Networks |
0 |
0 |
1 |
20 |
0 |
0 |
1 |
68 |
The Relation Between Global Migration and Trade Networks |
0 |
0 |
0 |
49 |
1 |
1 |
3 |
122 |
The Similarity of Global Value Chains: A Network-Based Measure |
0 |
0 |
0 |
56 |
0 |
1 |
1 |
143 |
The Similarity of Global Value Chains: A Network-Based Measure |
0 |
0 |
0 |
45 |
1 |
2 |
2 |
110 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
33 |
0 |
0 |
0 |
92 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
28 |
0 |
0 |
0 |
79 |
The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
37 |
0 |
2 |
4 |
103 |
The Structure and Growth of International Trade |
0 |
0 |
0 |
105 |
0 |
0 |
1 |
221 |
The Structure and Growth of International Trade |
0 |
0 |
0 |
24 |
0 |
0 |
22 |
162 |
The Structure and Growth of International Trade |
0 |
0 |
0 |
68 |
0 |
0 |
0 |
239 |
The Structure and Growth of Weighted Networks |
0 |
0 |
0 |
63 |
0 |
0 |
1 |
157 |
The Structure and Growth of World Trade, and the Role of Europe in the Global Economy |
0 |
0 |
0 |
37 |
0 |
0 |
0 |
93 |
The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
0 |
1 |
59 |
0 |
0 |
1 |
199 |
The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
45 |
The Value of Failures in Pharmaceutical R&D |
0 |
0 |
1 |
33 |
0 |
1 |
4 |
149 |
The evolution of networks of innovators within and across borders: Evidence from patent data |
0 |
0 |
0 |
149 |
2 |
3 |
4 |
226 |
The migration network effect on international trade |
0 |
0 |
1 |
120 |
0 |
0 |
1 |
183 |
The productivity crisis in pharmaceutical R&D |
0 |
0 |
1 |
179 |
0 |
1 |
4 |
511 |
The rise of China in the international trade network: a community core detection approach |
0 |
0 |
0 |
37 |
0 |
0 |
0 |
79 |
Virtual Water Trade and Bilateral Conflicts |
0 |
1 |
1 |
33 |
0 |
2 |
4 |
69 |
Where Gibrat meets Zipf: Scale and Scope of French Firms |
0 |
0 |
0 |
50 |
0 |
0 |
1 |
115 |
World Input-Output Network |
0 |
0 |
0 |
139 |
0 |
0 |
1 |
128 |
World Input-Output Network |
0 |
0 |
0 |
53 |
1 |
1 |
1 |
63 |
Total Working Papers |
5 |
6 |
50 |
5,690 |
25 |
55 |
242 |
17,612 |